≡

CLIA Kit for Interleukin 19 (IL19)

MDA1; ZMDA1, IL-10C, NG.1; Melanoma Differentiation Associated Protein-Like Protein

Specificity

This assay has high sensitivity and excellent specificity for detection of Interleukin 19 (IL19).
No significant cross-reactivity or interference between Interleukin 19 (IL19) and analogues was observed.

Recovery

Matrices listed below were spiked with certain level of recombinant Interleukin 19 (IL19) and the recovery rates were calculated by comparing the measured value to the expected amount of Interleukin 19 (IL19) in samples.

Matrix Recovery range (%) Average(%)
serum(n=5) 78-101 95
EDTA plasma(n=5) 80-97 93
heparin plasma(n=5) 89-99 95

Precision

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Interleukin 19 (IL19) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Interleukin 19 (IL19) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Linearity

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Interleukin 19 (IL19) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample 1:2 1:4 1:8 1:16
serum(n=5) 91-98% 85-105% 88-96% 83-95%
EDTA plasma(n=5) 85-99% 84-103% 83-97% 78-99%
heparin plasma(n=5) 85-95% 90-97% 78-104% 94-103%

Stability

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Reagents and materials provided

Reagents Quantity Reagents Quantity
Pre-coated, ready to use 96-well strip plate 1 Plate sealer for 96 wells 4
Standard 2 Standard Diluent 1×20mL
Detection Reagent A 1×120µL Assay Diluent A 1×12mL
Detection Reagent B 1×120µL Assay Diluent B 1×12mL
Substrate A 1×10mL Substrate B 1×2mL
Wash Buffer (30 × concentrate) 1×20mL Instruction manual 1

Assay procedure summary

1. Prepare all reagents, samples and standards;
2. Add 100µL standard or sample to each well. Incubate 1 hours at 37°C;
3. Aspirate and add 100µL prepared Detection Reagent A. Incubate 1 hour at 37°C;
4. Aspirate and wash 3 times;
5. Add 100µL prepared Detection Reagent B. Incubate 30 minutes at 37°C;
6. Aspirate and wash 5 times;
7. Add 100µL Substrate Solution. Incubate 10 minutes at 37°C;
8. Read RLU value immediately.

GIVEAWAYS

INCREMENT SERVICES

Magazine Citations
Cell Death & Disease The P2X7 receptor is a key modulator of aerobic glycolysis PubMed: 22898868
Middle East Journal of Cancer Decreased Serum Level of Interleukin-19 in Iranian Patients with Breast Cancer Index.Php: Mejc
Theranostics IL20RA signaling enhances stemness and promotes the formation of an immunosuppressive microenvironment in breast cancer 33456560
Catalog No. Related products for research use of Rattus norvegicus (Rat) Organism species Applications (RESEARCH USE ONLY!)
APB190Ra61 Active Interleukin 19 (IL19) Cell culture; Activity Assays.
EPB190Ra61 Eukaryotic Interleukin 19 (IL19) Positive Control; Immunogen; SDS-PAGE; WB.
RPB190Ra01 Recombinant Interleukin 19 (IL19) Positive Control; Immunogen; SDS-PAGE; WB.
PAB190Ra01 Polyclonal Antibody to Interleukin 19 (IL19) WB; IHC; ICC; IP.
MAB190Ra21 Monoclonal Antibody to Interleukin 19 (IL19) WB; IHC; ICC; IP.
SEB190Ra ELISA Kit for Interleukin 19 (IL19) Enzyme-linked immunosorbent assay for Antigen Detection.
SCB190Ra CLIA Kit for Interleukin 19 (IL19) Chemiluminescent immunoassay for Antigen Detection.
LMB190Ra Multiplex Assay Kit for Interleukin 19 (IL19) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.